Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis

Fig. 1

SNHG17 was up-regulated in astrocytoma cell lines and promoted the process of astrocytoma cells (a) SNHG17 expression was detected in astrocytoma cell lines (LN-215, ADF, U138 and A-382) and human astrocytes (NHA). b SNHG17 expression was examined in cells transfected with sh-SNHG17#1/2. c-d EdU assays and CCK8 assessed proliferation in sh-SNHG17#1/2 and sh-NC group. e-f Flow cytometry analysis and TUNEL appraised apoptosis in different groups. g-h Sphere formation efficiency was assessed by sphere formation assay and the expression of stemness-associated markers was measured by RT-qPCR. i-j Transwell assays evaluated cell migration and invasion in different groups. *P < 0.05, **P < 0.01

Back to article page